News

HackZurich and Digital Festival impressed the European technology and digital scene

The 8th HackZurich competition was held at Technopark Zurich from Friday to Sunday. From a large number of international applications, more than 1,500 programmers and developers were selected, who developed more than 150 innovative and technical models in teams within 40 hours. In addition to the 420 site participants, more than 600 participants from nearly all over the world took part.

weiterlesen

10 Venture Leaders Deeptech selected

As part of the Venture Leaders program, ten start-ups will showcase Switzerland’s deeptech expertise and lay the foundation for their global growth. Pitching in front of international investors, networking with experts and industry leaders, and learning from each other’s entrepreneurial experience will ensure the startups get ready for internationalization and fundraising success.

weiterlesen

Versantis receives U.S. FDA Orphan Drug Designation for VS-01

Versantis AG, a clinical-stage company developing novel therapies for rare liver diseases and rare pediatric diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its lead product candidate VS-01 for the treatment of hyperammonemia (HA) in inborn errors of metabolism (IEM).

weiterlesen

Additional funds for Positrigo

With a further EUR 1.5 million from the European Innovation Council EIC Fund, Technopark Zurich based  Medtech Positrigo is one of the first companies to receive equity funding under the EIC Accelerator programme. The funds will contribute to the second tranche of Positrigo’s series A and support the start-up’s breakthrough brain PET scanner technology.

weiterlesen